JP2023520703A - コロナウイルス感染症の防止および治療における使用のためのシアル酸組成物 - Google Patents

コロナウイルス感染症の防止および治療における使用のためのシアル酸組成物 Download PDF

Info

Publication number
JP2023520703A
JP2023520703A JP2022560329A JP2022560329A JP2023520703A JP 2023520703 A JP2023520703 A JP 2023520703A JP 2022560329 A JP2022560329 A JP 2022560329A JP 2022560329 A JP2022560329 A JP 2022560329A JP 2023520703 A JP2023520703 A JP 2023520703A
Authority
JP
Japan
Prior art keywords
sialic acid
use according
nana
acid
cov
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022560329A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520703A5 (https=
Inventor
レメレイト，ジャン
Original Assignee
ライフサイエンス エイエス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライフサイエンス エイエス filed Critical ライフサイエンス エイエス
Publication of JP2023520703A publication Critical patent/JP2023520703A/ja
Publication of JP2023520703A5 publication Critical patent/JP2023520703A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2022560329A 2020-04-01 2021-03-31 コロナウイルス感染症の防止および治療における使用のためのシアル酸組成物 Pending JP2023520703A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063003477P 2020-04-01 2020-04-01
US63/003,477 2020-04-01
PCT/IB2021/000200 WO2021198774A1 (en) 2020-04-01 2021-03-31 Sialic acid compositions for use in inhibiting and treating coronavirus infection

Publications (2)

Publication Number Publication Date
JP2023520703A true JP2023520703A (ja) 2023-05-18
JP2023520703A5 JP2023520703A5 (https=) 2024-04-09

Family

ID=76250375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560329A Pending JP2023520703A (ja) 2020-04-01 2021-03-31 コロナウイルス感染症の防止および治療における使用のためのシアル酸組成物

Country Status (9)

Country Link
US (3) US11813271B2 (https=)
EP (1) EP4125926A1 (https=)
JP (1) JP2023520703A (https=)
KR (1) KR20220161413A (https=)
CN (1) CN115461057A (https=)
AU (1) AU2021247584B2 (https=)
BR (1) BR112022019685A2 (https=)
CA (1) CA3173633A1 (https=)
WO (1) WO2021198774A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230226088A1 (en) * 2020-06-09 2023-07-20 The Texas A&M University System Therapeutics for treatment of covid-19 symptoms
WO2023104402A1 (en) 2021-12-09 2023-06-15 Frieslandcampina Nederland B.V. Milk fraction that inhibits covid-19 infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
EP2364139A2 (en) * 2008-11-10 2011-09-14 Life Science Nutrition AS Ngna compositions and methods of use
AU2010315024B2 (en) * 2009-11-06 2015-02-12 Nexbio, Inc. Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract
CN111787925A (zh) * 2017-10-11 2020-10-16 生命科学股份有限公司 N-乙酰神经氨酸组合物和使用方法
CN111481560A (zh) * 2020-04-23 2020-08-04 菌维他(北京)医疗科技有限公司 唾液酸及衍生物在制备防治冠状病毒疾病的药品中的应用
CN111658631A (zh) 2020-06-11 2020-09-15 广东盛普生命科技有限公司 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CELL REP, vol. 27(11):3284-3294, JPN6025016228, 2019, ISSN: 0005587339 *
INT J BIOL SCI, vol. 16(10):1708-1717, JPN6025016229, 15 March 2020 (2020-03-15), ISSN: 0005587338 *
NAT STRUCT MOL BIOL, vol. 26:481-489, JPN6025016227, 2019, ISSN: 0005587340 *
REV MED VIROL, vol. 13:85-97, JPN6025016230, 2003, ISSN: 0005765041 *

Also Published As

Publication number Publication date
US20260083762A1 (en) 2026-03-26
US20240148763A1 (en) 2024-05-09
KR20220161413A (ko) 2022-12-06
WO2021198774A1 (en) 2021-10-07
AU2021247584A1 (en) 2022-10-20
BR112022019685A2 (pt) 2022-11-22
CA3173633A1 (en) 2021-10-07
EP4125926A1 (en) 2023-02-08
CN115461057A (zh) 2022-12-09
US11813271B2 (en) 2023-11-14
US12390481B2 (en) 2025-08-19
US20230128687A1 (en) 2023-04-27
AU2021247584B2 (en) 2023-11-02

Similar Documents

Publication Publication Date Title
US11672814B2 (en) NGNA compositions and methods of use
US20260083762A1 (en) Sialic acid compositions for the use of inhibiting and treating coronavirus infection
EP3694524B1 (en) N-acetylneuraminic acid compositions and their use for inhibiting or treating ailments of the upper respiratory tract
AU2010335594B2 (en) Synergistic antiviral composition and use thereof
CA3030971A1 (en) Methods for treating cystic fibrosis and other diseases affecting mucosal surfaces
EP3154515A1 (en) Improvements to nasal compositions and method of use thereof
US20230165851A1 (en) 6'-methoxycinchonan-9-ols for the treatment of coronaviral infections
US11752108B2 (en) Gold particles including an oleo-gum resin and/or a derivative thereof and methods of preparing and using the same
HK40084501A (en) Sialic acid compositions for use in inhibiting and treating coronavirus infection
CN115209954B (zh) 用于治疗呼吸系统病变的组合物
US20230233456A1 (en) Compositions and methods for treating coronavirus
WO2026072659A1 (en) Formulations of segmented filamentous bacteria-induced metabolites and methods of use thereof
RO138617A0 (ro) Compoziţie farmaceutică inovatoare sub formă de spray oral pentru sănătatea respiratorie

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250801

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250916

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260401